336 related articles for article (PubMed ID: 32865982)
1. Development of Ubiquitin Variants with Selectivity for Ubiquitin C-Terminal Hydrolase Deubiquitinases.
Hewitt CS; Krabill AD; Das C; Flaherty DP
Biochemistry; 2020 Sep; 59(37):3447-3462. PubMed ID: 32865982
[TBL] [Abstract][Full Text] [Related]
2. Rational Development and Characterization of a Ubiquitin Variant with Selectivity for Ubiquitin C-Terminal Hydrolase L3.
Hewitt CS; Das C; Flaherty DP
Biomolecules; 2022 Jan; 12(1):. PubMed ID: 35053210
[TBL] [Abstract][Full Text] [Related]
3. Ubiquitin C-Terminal Hydrolase L1 regulates autophagy by inhibiting autophagosome formation through its deubiquitinating enzyme activity.
Yan C; Huo H; Yang C; Zhang T; Chu Y; Liu Y
Biochem Biophys Res Commun; 2018 Mar; 497(2):726-733. PubMed ID: 29462615
[TBL] [Abstract][Full Text] [Related]
4. Abolishing UCHL1's hydrolase activity exacerbates TBI-induced axonal injury and neuronal death in mice.
Mi Z; Liu H; Rose ME; Ma X; Reay DP; Ma J; Henchir J; Dixon CE; Graham SH
Exp Neurol; 2021 Feb; 336():113524. PubMed ID: 33159930
[TBL] [Abstract][Full Text] [Related]
5. Covalent Fragment Screening and Optimization Identifies the Chloroacetohydrazide Scaffold as Inhibitors for Ubiquitin C-terminal Hydrolase L1.
Imhoff RD; Patel R; Safdar MH; Jones HBL; Pinto-Fernandez A; Vendrell I; Chen H; Muli CS; Krabill AD; Kessler BM; Wendt MK; Das C; Flaherty DP
J Med Chem; 2024 Mar; 67(6):4496-4524. PubMed ID: 38488146
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitin dimers control the hydrolase activity of UCH-L3.
Setsuie R; Sakurai M; Sakaguchi Y; Wada K
Neurochem Int; 2009; 54(5-6):314-21. PubMed ID: 19154770
[TBL] [Abstract][Full Text] [Related]
7. On the Study of Deubiquitinases: Using the Right Tools for the Job.
Caba C; Mohammadzadeh A; Tong Y
Biomolecules; 2022 May; 12(5):. PubMed ID: 35625630
[TBL] [Abstract][Full Text] [Related]
8. Structural basis for specific inhibition of the deubiquitinase UCHL1.
Grethe C; Schmidt M; Kipka GM; O'Dea R; Gallant K; Janning P; Gersch M
Nat Commun; 2022 Oct; 13(1):5950. PubMed ID: 36216817
[TBL] [Abstract][Full Text] [Related]
9. Structural and functional characterization of ubiquitin variant inhibitors for the JAMM-family deubiquitinases STAMBP and STAMBPL1.
Guo Y; Liu Q; Mallette E; Caba C; Hou F; Fux J; LaPlante G; Dong A; Zhang Q; Zheng H; Tong Y; Zhang W
J Biol Chem; 2021 Oct; 297(4):101107. PubMed ID: 34425109
[TBL] [Abstract][Full Text] [Related]
10. Essential role of maternal UCHL1 and UCHL3 in fertilization and preimplantation embryo development.
Mtango NR; Sutovsky M; Susor A; Zhong Z; Latham KE; Sutovsky P
J Cell Physiol; 2012 Apr; 227(4):1592-603. PubMed ID: 21678411
[TBL] [Abstract][Full Text] [Related]
11. Reversible monoubiquitination regulates the Parkinson disease-associated ubiquitin hydrolase UCH-L1.
Meray RK; Lansbury PT
J Biol Chem; 2007 Apr; 282(14):10567-75. PubMed ID: 17259170
[TBL] [Abstract][Full Text] [Related]
12. Ubiquitin C-terminal hydrolases cleave isopeptide- and peptide-linked ubiquitin from structured proteins but do not edit ubiquitin homopolymers.
Bett JS; Ritorto MS; Ewan R; Jaffray EG; Virdee S; Chin JW; Knebel A; Kurz T; Trost M; Tatham MH; Hay RT
Biochem J; 2015 Mar; 466(3):489-98. PubMed ID: 25489924
[TBL] [Abstract][Full Text] [Related]
13. Ubiquitin carboxyl-terminal hydrolase L1, a novel deubiquitinating enzyme in the vasculature, attenuates NF-kappaB activation.
Takami Y; Nakagami H; Morishita R; Katsuya T; Cui TX; Ichikawa T; Saito Y; Hayashi H; Kikuchi Y; Nishikawa T; Baba Y; Yasuda O; Rakugi H; Ogihara T; Kaneda Y
Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2184-90. PubMed ID: 17690318
[TBL] [Abstract][Full Text] [Related]
14. Control of BACE1 degradation and APP processing by ubiquitin carboxyl-terminal hydrolase L1.
Zhang M; Deng Y; Luo Y; Zhang S; Zou H; Cai F; Wada K; Song W
J Neurochem; 2012 Mar; 120(6):1129-38. PubMed ID: 22212137
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitin C-Terminal Hydrolase L1 (UCH-L1) Promotes Hippocampus-Dependent Memory via Its Deubiquitinating Effect on TrkB.
Guo YY; Lu Y; Zheng Y; Chen XR; Dong JL; Yuan RR; Huang SH; Yu H; Wang Y; Chen ZY; Su B
J Neurosci; 2017 Jun; 37(25):5978-5995. PubMed ID: 28500221
[TBL] [Abstract][Full Text] [Related]
16. Plant deubiquitinases: from structure and activity to biological functions.
Luo R; Yang K; Xiao W
Plant Cell Rep; 2023 Mar; 42(3):469-486. PubMed ID: 36567335
[TBL] [Abstract][Full Text] [Related]
17. Yeast Two-Hybrid Analysis for Ubiquitin Variant Inhibitors of Human Deubiquitinases.
Pascoe N; Seetharaman A; Teyra J; Manczyk N; Satori MA; Tjandra D; Makhnevych T; Schwerdtfeger C; Brasher BB; Moffat J; Costanzo M; Boone C; Sicheri F; Sidhu SS
J Mol Biol; 2019 Mar; 431(6):1160-1171. PubMed ID: 30763569
[TBL] [Abstract][Full Text] [Related]
18. Characterization of Deubiquitinase Catalytic State Using a Structure-Based Approach.
Zhang Z; Das C
Methods Mol Biol; 2023; 2591():1-15. PubMed ID: 36350539
[TBL] [Abstract][Full Text] [Related]
19. Essential role of ubiquitin C-terminal hydrolases UCHL1 and UCHL3 in mammalian oocyte maturation.
Mtango NR; Sutovsky M; Vandevoort CA; Latham KE; Sutovsky P
J Cell Physiol; 2012 May; 227(5):2022-9. PubMed ID: 21751213
[TBL] [Abstract][Full Text] [Related]
20. Ubiquitin carboxyl-terminal hydrolases: involvement in cancer progression and clinical implications.
Fang Y; Shen X
Cancer Metastasis Rev; 2017 Dec; 36(4):669-682. PubMed ID: 29080080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
